Medifast, Inc. (MED)

Market Cap	121.48M
Revenue (ttm)	429.70M
Net Income (ttm)	248,000
Shares Out	10.28M
EPS (ttm)	0.02
PE Ratio	592.33
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	212,231
Open	11.79
Previous Close	11.83
Day's Range	11.68 - 11.86
52-Week Range	10.10 - 16.66
Beta	0.50
Analysts	Hold
Price Target	16.50 (+39.59%)
Earnings Date	Feb 17, 2026

About MED

Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address obesity and support a healthy life in the United States. The company offers weight loss and weight management plans; and GLP-1 support plans that provide access to GLP-1 medications where clinically appropriate under the OPTAVIA brand name. It also provides bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and sou...

• Industry: Personal Services
• Sector: Consumer Discretionary
• Founded: 1980
• Employees: 504
• Stock Exchange: NYSE
• Ticker Symbol: MED
• Website: https://medifastinc.com

Financial Performance

In 2024, Medifast's revenue was $602.46 million, a decrease of -43.80% compared to the previous year's $1.07 billion. Earnings were $2.09 million, a decrease of -97.90%.

Analyst Summary

According to one analyst, the rating for MED stock is "Hold" and the 12-month stock price target is $16.5.

Price Target

$16.5

(39.59% upside)

Analyst Consensus: Hold